NCT01542580 A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01534884 Demonstrate the Equivalence of CT-P10 to MabThera With Respect to the Pharmacokinetic Profile in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01534871 The Effects of Cardiac Rehabilitation on Cardiovascular Disease Risk in Rheumatoid Arthritis Patients Status COMPLETED Phase NA
NCT01533714 The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01526434 Health-related Quality of Life and Patient-reported Outcomes in Rheumatoid Arthritis Patients Treated With Certolizumab Pegol Status COMPLETED Phase N/A
NCT01526057 A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) Status COMPLETED Phase PHASE2
NCT01521923 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01521884 Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy Status COMPLETED Phase N/A
NCT01519791 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01519375 Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI) Status COMPLETED Phase N/A
NCT01511926 Descriptive Study in Patients Treated With Vimovo™, Including Registration of the Physicians' Prescribing Patterns Status COMPLETED Phase N/A
NCT01511003 A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs) Status COMPLETED Phase PHASE4
NCT01502423 A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab Status COMPLETED Phase PHASE2
NCT01500278 Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate Status COMPLETED Phase PHASE4
NCT01499732 Exploratory Trial to Evaluate Premature Endothelial Dysfunction in Early Rheumatoid Arthritis(RA)Compared to Patients With Established RA, and Normal Subjects Status COMPLETED Phase N/A
NCT01491815 Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction Status UNKNOWN Phase PHASE4
NCT01489384 Cimzia Treatment in Rheumatoid Arthritis: Randomizing to Stop Versus Continue Disease-modifying Anti-rheumatic Drug(s) Status UNKNOWN Phase N/A
NCT01483326 An Observational Study on Long-Term Efficacy and Safety of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis (FAct) Status COMPLETED Phase N/A